Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04043676
Title Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fundacion Teofilo Hernando, Spain
Indications

chronic myeloid leukemia

Therapies

Ponatinib

Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.